Meeting Register Page

ASPI premieres AS 101 segments on genetics and genomics

Do you know the difference between genetic and genomic testing and how it can impact your decisions on whether to follow Active Surveillance protocols vs. more aggressive surgical and radiation options? ASPI is premiering a segment of the AS 101 series aimed at educating patients about the differences between genetic and genomic testing. AS 101, like an introductory college course, was launched in 2022 to explain in short video chats the basics of active surveillance for the newly diagnosed, those in the “gray zone” with rising PSAs but no biopsy confirming the presence of low-risk cancer, and also patients who have been on AS for a while but are looking for a refresher course.

Mar 25, 2023 12:00 PM in Eastern Time (US and Canada)